CATHETER SITE VESICLES

CATHETER SITE VESICLES was reported 195 times

CATHETER SITE VESICLES is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Prostacycline Vasodilator [EPC] 129 0.0009
1 Plasma Kallikrein Inhibitor [EPC] 2 0.0008
2 Soluble Guanylate Cyclase Stimulator [EPC] 24 0.0007
3 Phosphodiesterase 5 Inhibitor [EPC] 63 0.0005
4 Non-Standardized Fungal Allergenic Extract [EPC] 1 0.0005
5 alpha-Hydroxy Acid [EPC] 1 0.0005
6 Endothelin Receptor Antagonist [EPC] 91 0.0005
7 Barbiturate [EPC] 3 0.0003
8 Prostacyclin Receptor Agonist [EPC] 6 0.0002
9 Sigma-1 Agonist [EPC] 2 0.0002
10 Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] 2 0.0001
11 Thyroid Hormone Synthesis Inhibitor [EPC] 1 0.0001
12 Leukotriene Receptor Antagonist [EPC] 3 0.0001
13 Antifibrinolytic Agent [EPC] 1 0.0001
14 Antisense Oligonucleotide [EPC] 1 0.0001
15 Cardiac Glycoside [EPC] 6 0.0001
16 Aldosterone Antagonist [EPC] 13 0.0001
17 Aromatic Amino Acid [EPC] 5 0.0001
18 Thiazide-like Diuretic [EPC] 3 0.0001
19 Loop Diuretic [EPC] 28 0.0001
20 Osmotic Laxative [EPC] 17 0.0001
21 Tetracycline-class Drug [EPC] 4 0.0001
22 gamma-Aminobutyric Acid-ergic Agonist [EPC] 5 0.0001
23 Cholinesterase Inhibitor [EPC] 1 0.0001
24 CD52-directed Cytolytic Antibody [EPC] 1 0.0001
25 Methylxanthine [EPC] 3 0.0001
26 Factor Xa Inhibitor [EPC] 13 0.0000
27 Histamine-2 Receptor Antagonist [EPC] 6 0.0000
28 Serotonin-3 Receptor Antagonist [EPC] 6 0.0000
29 Bile Acid [EPC] 1 0.0000
30 Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 5 0.0000
31 Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 5 0.0000
32 Aluminum Complex [EPC] 1 0.0000
33 Radiographic Contrast Agent [EPC] 1 0.0000
34 Arteriolar Vasodilator [EPC] 3 0.0000
35 Central Nervous System Stimulant [EPC] 3 0.0000
36 Sympathomimetic-like Agent [EPC] 1 0.0000
37 Glycopeptide Antibacterial [EPC] 2 0.0000
38 Expectorant [EPC] 5 0.0000
39 alpha-Adrenergic Blocker [EPC] 3 0.0000
40 Proton Pump Inhibitor [EPC] 12 0.0000
41 Purine Antimetabolite [EPC] 2 0.0000
42 Calcium [EPC] 3 0.0000
43 5-alpha Reductase Inhibitor [EPC] 2 0.0000
44 Central alpha-2 Adrenergic Agonist [EPC] 1 0.0000
45 Dihydropyridine Calcium Channel Blocker [EPC] 6 0.0000
46 Platelet Aggregation Inhibitor [EPC] 10 0.0000
47 Xanthine Oxidase Inhibitor [EPC] 3 0.0000
48 Vitamin C [EPC] 7 0.0000
49 Sulfonylurea [EPC] 2 0.0000
50 Fluoroquinolone Antibacterial [EPC] 2 0.0000
51 Nitroimidazole Antimicrobial [EPC] 1 0.0000
52 Opioid Agonist [EPC] 4 0.0000
53 Platinum-based Drug [EPC] 4 0.0000
54 HER2/neu Receptor Antagonist [EPC] 1 0.0000
55 Nonsteroidal Anti-inflammatory Drug [EPC] 17 0.0000
56 Non-Standardized Chemical Allergen [EPC] 1 0.0000
57 Catecholamine [EPC] 1 0.0000
58 Estrogen [EPC] 2 0.0000
59 Benzodiazepine [EPC] 7 0.0000
60 beta-Adrenergic Blocker [EPC] 3 0.0000
61 Thiazide Diuretic [EPC] 2 0.0000
62 Insulin Analog [EPC] 4 0.0000
63 Proteasome Inhibitor [EPC] 1 0.0000
64 Corticosteroid [EPC] 11 0.0000
65 P2Y12 Platelet Inhibitor [EPC] 1 0.0000
66 Alkylating Drug [EPC] 2 0.0000
67 Progestin [EPC] 2 0.0000
68 Azole Antifungal [EPC] 1 0.0000
69 Vitamin B12 [EPC] 2 0.0000
70 Phosphodiesterase 4 Inhibitor [EPC] 1 0.0000
71 Microtubule Inhibitor [EPC] 1 0.0000
72 HMG-CoA Reductase Inhibitor [EPC] 2 0.0000
73 Anti-epileptic Agent [EPC] 1 0.0000
74 GLP-1 Receptor Agonist [EPC] 2 0.0000
75 Vitamin D [EPC] 1 0.0000
76 Folate Analog Metabolic Inhibitor [EPC] 1 0.0000
77 Thalidomide Analog [EPC] 1 0.0000
78 Kinase Inhibitor [EPC] 1 0.0000